BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 11978574)

  • 1. Autoimmune polyglandular syndrome (APS) type 1 and candida onychomycosis.
    Manz B; Scholz GH; Willgerodt H; Haustein UF; Nenoff P
    Eur J Dermatol; 2002; 12(3):283-6. PubMed ID: 11978574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [APS I--a severe autoimmune disease with endocrine and non-endocrine symptoms].
    Gustafsson J; Alimohammadi M; Ekwall O; Gebre-Medhin G; Halldin-Stenlid M; Hedstrand H; Landgren E; Nilsson T; Rorsman F; Sköldberg F; Winqvist O; Kämpe O
    Lakartidningen; 2004 Jun; 101(24):2096-8, 2101-3. PubMed ID: 15282984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune polyendocrinopathy and chronic mucocutaneous candidiasis].
    Delambre C; Teillac D; Brauner R; de Prost Y
    Ann Dermatol Venereol; 1989; 116(2):117-21. PubMed ID: 2660706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic consequences of autoimmune polyglandular syndrome type 1.
    Berger JR; Weaver A; Greenlee J
    Neurology; 2008 Jun; 70(23):2248-51. PubMed ID: 18519874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1.
    Lankisch TO; Jaeckel E; Strassburg CP
    Semin Liver Dis; 2009 Aug; 29(3):307-14. PubMed ID: 19676003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
    Collins SM; Dominguez M; Ilmarinen T; Costigan C; Irvine AD
    Br J Dermatol; 2006 Jun; 154(6):1088-93. PubMed ID: 16704638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune multiglandular syndrome type I--a case study].
    Dunajska K; Szymczak J
    Pol Merkur Lekarski; 2004 Dec; 17(102):625-8. PubMed ID: 15771137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Familial chronic mucocutaneous candidiasis associated with autoimmune polyendocrinopathy. Treatment with fluconazole: 3 cases].
    Rybojad M; Abimelec P; Feuilhade M; Morel P; Bourrat E
    Ann Dermatol Venereol; 1999 Jan; 126(1):54-6. PubMed ID: 10095896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anogenital condylomata acuminata, mucocutaneous candidiasis, vitiligo, keratopathy and primary hypoparathyroidism in an autoimmune polyglandular syndrome type 1].
    Oblinger E; Cibis A; Peter RU; Proebstle TM
    Dtsch Med Wochenschr; 1997 Nov; 122(45):1382-6. PubMed ID: 9410715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune polyglandular syndrome].
    Inaba M
    Nihon Rinsho; 1999 Aug; 57(8):1888-93. PubMed ID: 10483271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune polyglandular syndrome type I. A case report.
    Cinaz P; Bideci A; Haznedaroğlu A; Ezgü FS; Ağaoğlu O; Kürşaklioğlu S
    Turk J Pediatr; 1997; 39(2):271-5. PubMed ID: 9223927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucocutaneous candidiasis as first manifestation of autoimmune polyglandular syndrome type I.
    López-Jornet P; García-Ballesta C; Pérez-Lajarín L
    J Dent Child (Chic); 2005; 72(1):21-4. PubMed ID: 16119071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune polyglandular syndrome associated with idiopathic giant cell myocarditis.
    Schumann C; Faust M; Gerharz M; Ortmann M; Schubert M; Krone W
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):302-7. PubMed ID: 15926118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enamel hypoplasia secondary to candidiasis endocrinopathy syndrome: case report.
    Porter SR; Eveson JW; Scully C
    Pediatr Dent; 1995; 17(3):216-9. PubMed ID: 7617499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida onychomycosis in HIV infection.
    Tosti A; Piraccini BM; Lorenzi S; D'Antuono A
    Eur J Dermatol; 1998; 8(3):173-4. PubMed ID: 9653014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoimmune polyendocrine syndrome type 2 associated with autoimmune hypophysitis and coeliac disease].
    Hrubisková K; Jackuliak P; Vanuga P; Pura M; Payer J
    Vnitr Lek; 2010 Nov; 56(11):1169-76. PubMed ID: 21250496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune polyendocrinopathy and chronic mucocutaneous candidiasis].
    Proto G; Leoni S; Torossi I; Mazzolini A; Grimaldi F; Bertolissi F
    Minerva Med; 1992; 83(7-8):475-8. PubMed ID: 1522973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polyglandular autoimmune type I syndrome with hypoparathyroidism, chronic mucocutaneous candidiasis and intestinal malabsorption].
    Hayashida CY; Toledo SP; Barros MT; Ezabella MC; Laudanna AA
    Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(1):24-8. PubMed ID: 2133167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on autoimmune polyendocrine syndromes (APS).
    Betterle C; Zanchetta R
    Acta Biomed; 2003 Apr; 74(1):9-33. PubMed ID: 12817789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbinafine effectiveness in ketoconazole-resistant mucocutaneous candidasis in polyglandular autoimmune syndrome type 1.
    Hassan G
    J Assoc Physicians India; 2003 Mar; 51():323. PubMed ID: 12839367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.